J. Scott Garland Insider Trading $KPTI Karyopharm Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for J. Scott Garland.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of J. Scott Garland. J. Scott Garland is EVP & Chief Commerical Officer in EXELIXIS, INC. ($EXEL) and President and CEO in PORTOLA PHARMACEUTICALS INC ($PTLA) and SVP & Chief Commercial Officer in Relypsa Inc ($RLYP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Karyopharm Therapeutics Inc. ($KPTI).

J. Scott Garland in Karyopharm Therapeutics Inc.

Trading Symbol: KPTI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 07 2019
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of J. Scott Garland in Karyopharm Therapeutics Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CALA, EXEL, KPTI, PTLA, RLYP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Jun 07 2019	KPTI	Karyopharm Therape ...	Garland J. Scott	Director	Option Exercise	A	5.43	25,000	135,750	25,000
Jun 20 2018	KPTI	Karyopharm Therape ...	Garland J. Scott	Director	Option Exercise	A	18.80	17,000	319,600	17,000
Jun 16 2017	KPTI	Karyopharm Therape ...	Garland J. Scott	Director	Option Exercise	A	9.18	17,000	156,060	17,000
Jun 17 2016	KPTI	Karyopharm Therape ...	Garland J. Scott	Director	Option Exercise	A	8.06	10,000	80,600	10,000
May 26 2015	KPTI	Karyopharm Therape ...	Garland J. Scott	Director	Option Exercise	A	26.15	10,000	261,500	10,000

Page: 1